文献速递鼻科

富血小板血浆治疗药物性鼻炎:动物模型中的一项有前景的组织病理学研究

Platelet-Rich Plasma for Rhinitis Medicamentosa: A Promising Histopathological Study in an Animal Model.
PubMed 文献 · Otolaryngol Head Neck Surg · 2025-05-16

该研究在大鼠模型中评估鼻内富血小板血浆(PRP)对药物性鼻炎(RM)组织病理学改变的效果。40只Wistar白化大鼠随机分为五组,PRP治疗显著减轻黏膜下水肿并改善黏膜下腺体退变评分,且组织病理学总评分降低幅度大于激素治疗(P = .007)。作者认为PRP可能作为激素的替代选择。

要点

  • 鼻内PRP显著减轻药物性鼻炎大鼠模型的黏膜下水肿并改善黏膜下腺体退变评分。
  • PRP治疗的组织病理学总评分降低幅度大于激素治疗(P = .007)。
  • 作者认为PRP为自体产物、副作用风险低,可能作为激素的替代选择。

核心结论

  • PRP给药有效改善实验诱导的药物性鼻炎大鼠模型的黏膜下水肿、黏膜下腺体退变及组织病理学总评分。
  • 鉴于PRP为自体产物且副作用风险低,作者认为其可能作为激素治疗药物性鼻炎的有前景的替代选择。

研究设计与样本

  • 实验动物研究,在大学动物实验室进行。
  • 40只Wistar白化大鼠随机分为五组,评估不同治疗对药物性鼻炎的效果。

主要发现

  • 第1组鼻内给予生理盐水60天作为阴性对照;第2组鼻内给予羟甲唑啉连续60天诱导药物性鼻炎,断头后组织病理学评估确认造模成功。
  • 其余三组同样给予羟甲唑啉60天,随后15天分别给予组别特异性治疗:第3组生理盐水、第4组鼻内皮质激素、第5组鼻内PRP。
  • 鼻内PRP治疗显著减轻黏膜下水肿并改善黏膜下腺体退变评分。
  • PRP治疗的组织病理学总评分降低幅度大于激素治疗(P = .007)。

临床怎么用

  • 作者认为PRP可能作为激素治疗药物性鼻炎的有前景的替代选择,原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether platelet-rich plasma (PRP) has an efficacy on histopathologic changes in rhinitis medicamentosa (RM) in a rat model. STUDY DESIGN: Experimental animal study. SETTING: University animal laboratory. METHODS: Forty Wistar albino rats were randomly assigned to five groups to assess the effects of various treatments on RM. Group 1 received intranasal normal saline solution (NSS) for 60 days and served as the negative control. Group 2 was administered intranasal oxymetazoline for 60 consecutive days to induce RM. After decapitation, histopathological evaluation confirmed the development of RM in group 2. The remaining three groups were then similarly treated with oxymetazoline for 60 days. Following this period, group-specific treatments were applied for an additional 15 days: group 3 received NSS, group 4 was treated with intranasal corticosteroids, and group 5 received intranasal PRP. Nasal mucosal samples were harvested and subjected to histopathological evaluation to determine treatment-related changes. RESULTS: Intranasal PRP treatment significantly reduced submucosal edema and improved submucosal gland degeneration (SGD) scores in the nasal mucosa. Moreover, PRP treatment led to a greater reduction in total histopathological score compared to steroid treatment (P = .007). CONCLUSION: This study demonstrated that PRP administration effectively ameliorates submucosal edema, SGD, and total histopathologic score in experimentally induced RM. Given that PRP is an autologous product with a low risk of side effects, it may serve as a promising alternative to steroids in the treatment of RM.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Tulaci KG, Yayman S, Arslan E, et al. Platelet-Rich Plasma for Rhinitis Medicamentosa: A Promising Histopathological Study in an Animal Model. Otolaryngol Head Neck Surg. 2025. PMID: 40376757. doi:10.1002/ohn.1303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。